What you can and can’t expect from biosimilars.

All Episodes

October 26, 2022 • 12 mins

Guest: Sr. Vice President, Optum Rx Clinical and Formulary Services, Savitha Vivian. Long established in Europe, biosimilar alternatives to popular and costly biologic drugs are finally poised to make an impact in the U.S. With biosimilar alternatives to Humira now launching, what does that mean for prescription drug spending?

Mark as Played

Advertise With Us

Popular Podcasts

1. Stuff You Missed in History Class

Join Holly and Tracy as they bring you the greatest and strangest Stuff You Missed In History Class in this podcast by iHeartRadio.

2. Dateline NBC

Current and classic episodes, featuring compelling true-crime mysteries, powerful documentaries and in-depth investigations.

3. Crime Junkie

If you can never get enough true crime... Congratulations, you’ve found your people.

.css-15opob5{left:0;position:absolute;top:0.8rem;} All Episodes

.css-14f5ked{margin:0;word-break:break-word;display:-webkit-box;-webkit-box-orient:vertical;box-orient:vertical;-webkit-line-clamp:2;overflow:hidden;}What you can and can’t expect from biosimilars.